Search Results - clinical+and+disease+specializations+%3e+respiratory+diseases+%3e+acute+respiratory+distress+syndrome

2 Results Sort By:
Breathable Nanomedicine: Inhalable Angiotensin Blockers for Treating COVID-19 and Respiratory Infections
Value Proposition·      Provides targeted pulmonary delivery with superior lung pharmacokinetics·      Offers mutation-resistant therapeutic action, unlike current vaccines·      Reduces risk of progression to severe lung disease in newly diagnosed patients·      Applicable to a wide range of respiratory infections and ARDS-related conditions·      Enhances...
Published: 3/13/2026   |   Inventor(s): Jung Soo Suk, Daiqin Chen, Joe DiCostanzo, Axel Lehrer, Oreola Donini
Keywords(s):  
Category(s): Clinical and Disease Specializations > Infectious Diseases > Covid-19, Clinical and Disease Specializations > Infectious Diseases > Respiratory Infections, Clinical and Disease Specializations > Respiratory Diseases, Clinical and Disease Specializations > Respiratory Diseases > Acute Respiratory Distress Syndrome, Clinical and Disease Specializations > Infectious Diseases, Technology Classifications > Therapeutic Modalities, Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms, Technology Classifications > Therapeutic Modalities > Targets
Therapies to Accelerate Resolution of Acute Lung Inflammation
Acute respiratory distress syndrome (ARDS) is a devastating inflammatory lung disease for which there are no effective targeted therapies.  In experimental models of acute lung inflammation and injury, regulatory T cells (Tregs) orchestrate a pro-repair program; Tregs themselves are highly dependent on epigenetic mechanisms such as DNA hypomethylation. ...
Published: 3/12/2026   |   Inventor(s): Franco D'alessio, Landon King, Benjamin Singer, Neil Aggarwal
Keywords(s): Acute Respiratory Distress Syndrome, Acute Respiratory Distress Syndrome (ARDS), Antagonists/Inhibitors, Chemotherapy, Disease Indication, Immunotherapy, Lung Disorders, Non-novel, Predicted Novelty, Repurposed, Single, Small Molecules, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Respiratory Diseases > Acute Respiratory Distress Syndrome, Technology Classifications > Therapeutic Modalities, Technology Classifications > Therapeutic Modalities > Immunotherapies, Technology Classifications > Therapeutic Modalities > Small Molecules, Clinical and Disease Specializations > Respiratory Diseases, Technology Classifications > Therapeutic Modalities > Repurposed Drugs
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum